A new study conducted by researchers from the California Institute of Technology (Caltech) has uncovered a major breakthrough in the treatment of hepatitis. Through the use of a new technology, the researchers have discovered a new path that could lead to treatments that are more effective and successful than ever before.

The new technology, called CRISPR-based in vivo genome-wide mapping (CRISPR-IVGM), is able to detect and map out the complex network of genetic interactions that could be causing hepatitis. With this information, the researchers were able to disentangle the knotty pathways that cause this infectious disease, and can now begin to create treatments that could be more specific and efficient. The team hopes that this new technology could lead to the development of personalized treatments for hepatitis that could lead to better outcomes for patients.

Read Full Article Here

source: Phys.org